A novel management of diabetes by means of strong antioxidants' combination

Journal of Medical Hypotheses and Ideas

Volumn 7, Issue 1, 2013, Pages 25-30

  Tabatabaei Malazy, Ozra ^a   Larijani, Bagher ^a   Abdollahi, Mohammad ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Curcumin; Diabetes; Herbal products; IMOD; Insulin; Quercetin

Indexed keywords

ANTIOXIDANT; CURCUMIN; GLIBENCLAMIDE; METFORMIN; QUERCETIN; SATURUD; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; DIABETES MELLITUS; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG STRUCTURE; HUMAN; NONHUMAN; STREPTOZOCIN DIABETES;

EID: 84879031110     PISSN: 22517294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhi.2012.12.002     Document Type: Article

References (54)

1. IDF diabetes atlas. 5th ed. International Diabetes Federation; 2011, www.idf.org/diabetesatlas/papers.
2. Abdollahi M, Ranjbar A, Shadnia S, Nikfar S, Rezaie A. Pesticides and oxidative stress: a review. Med Sci Monit 2004;10:RA141-7.
3. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005;59:365-73.
4. Harris M, Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance. In: Alberti K, Zimmet P, Defronzo R, editors. International textbook of diabetes mellitus. Chichester: John Wiley and Sons; 1997. p. 9-23.
5. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci 2008;4:285-92.
6. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm Allergy Drug Targets 2009;8:2-10.
7. Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs for the treatment of diabetes. J Clin Biochem Nutr 2007;40:163-73.
8. Tabatabaei-Malazy O, Larijani B, Abdollahi M. A systematic review of in vitro studies conducted on effect of herbal products on secretion of insulin from Langerhans islets. J Pharm Pharm Sci 2012;15:447-66.
9. Hosseini A, Abdollahi M. Antioxidants as an appropriate approach to improve the outcome of pancreatic islet isolation: evidences from animal studies. Asian J Anim Ver Adv 2012;7:540-1.
10. Hosseini A, Abdollahi M. It is time to formulate an antioxidant mixture for management of diabetes and its complications: notice for pharmaceutical industries. Int J Pharmacol 2012;8:60-1.
11. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010;80:1895-903.
12. Novitsky Y, Madani H, Gharibdoust F, Farhadi M, Farzamfar B, Mohraz M. European patent application 2007. EP Patent No. EP 2 087 825 A3.
13. Mohseni Salehi Monfared SS, Pournourmohammadi S. Teucrium polium complex with molybdate enhance cultured islets secretory function. Biol Trace Elem Res 2010;133:236-41.
14. Larijani B, Salimi M, Pourkhalili N, Mohammadirad A, Baeeri M, Nili-Ahmadabadi A, et al.. Positive response of isolated rat pancreatic islets to IMOD; hopes for better transplant outcome and graft function. Asian J Anim Vet Adv 2011;6:1019-25.
15. Litwinienko G, Ingold K. Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J Org Chem 2004;69:5888-96.
16. Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012;39:283-99.
17. Mitjavila MT, Moreno JJ. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem Pharmacol 2012;84:1113-22.
18. Tang NP, Zhou B, Wang B, Yu RB, Ma J. Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 2009;39:352-9.
19. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50.
20. Babujanarthanam R, Kavitha P, Pandian MR. Quercetin, a bioflavonoid improves glucose homeostasis in streptozotocininduced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam Clin Pharmacol 2010;24:357-64.
21. Shao L, Liu K, Huang F, Guo X, Wang M, Liu B. Opposite effects of quercetin, luteolin and epigallocatechingallate on insulin sensitivity under normal and inflammatory conditions in mice. Inflammation 2012. http://dx.doi.org/10.1007/s10753-012-9514-x.
22. Vessal M, Hemmati M, Vasie M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol Toxicol Pharmacol 2003;135:357-64.
23. Oršolić N, Gajski G, Garaj-Vrhovac V, Dikić D, Prskalo Zš, Sirovina D. DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice. Eur J Pharmacol 2011;656:110-8.
24. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 2004;134:S3479-85.
25. Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012;83:6-15.
26. Mohseni-Salehi-Monfared SS, Larijani B, Abdollahi M. Islet transplantation and antioxidant management: a comprehensive review. World J Gastroenterol 2009;15:1153-61.
27. Baghaei A, Esmaily H, Abdolghaffari AH, Baeeri M, Gharibdoost F, Abdollahi M. Efficacy of Setarud (IMOD), a novel drug with potent anti-toxic stress potential in rat inflammatory bowel disease and comparison with dexamethasone and infliximab. Indian J Biochem Biophys 2010;47:219-26.
28. Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, Akbari-Gillani N. Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatol 2011;1:13-7.
29. Mohammadi M, Atashpour S, Pourkhalili N, Nili-Ahmadabadi A, Baeeri M, Mohammadirad A, et al.. Comparative improvement in function of isolated rat Langerhans islets by various phosphodiesterase 3, 4 and 5 inhibitors. Asian J Anim Vet Adv 2011;12:1233-40.
30. Rezvanfar MA, Rezvanfar MA, Ahmadi A, Shojaei-Saadi HA, Baeeri M, Abdollahi M. Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary. Theriogenology 2012;78(3):620-31.
31. Mahmoodpoor A, Eslami K, Mojtahedzadeh M, Najafi A, Ahmadi A, Dehnadi-Moghadam A, et al.. Examination of Setarud (IMOD™) in the management of patients with severe sepsis. DARU 2010;18:23-8.
32. Mohraz M, Khairandish P, Kazerooni PA, Davarpanah MA, Shahhosseiny MH, Mahdavian B, et al.. A clinical trial on the efficacy of IMOD in AIDS patients. DARU 2009;17:277-84.
33. Mehri A, Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of efficacy and safety of Urtica dioica in the treatment of diabetes. Int J Pharmacol 2011;7:161-70.
34. Bitiren M, Musa D, Ozgonul A, Ozaslan M, Kocyigit A, Sogut O, et al.. Protective effects of green tea (Camelia sinensis), Hypericum perforatum and Urtica dioica on hepatic injury and lymphocyte DNA damage induced by carbon tetrachloride in Wistar rats. Int J Pharmacol 2010;6:241-8.
35. Hassani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of Teucrium species; from anti-oxidant to anti-diabetic effects. Int J Pharmacol 2010;7:315-25.
36. Miroliaee AE, Esmaily H, Vaziri-Bami A, Baeeri M, Shahverdi AR, Abdollahi M. Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Toxicol Mech Methods 2011;21:200-8.
37. Khorram Khorshid HR, Novitsky YA, Abdollahi M, Shahhosseiny MH, Sadeghi B, Madani H, et al.. Studies on potential mutagenic and genotoxic activity of Setarud. DARU 2008;16:223-8.
38. TM), a novel immunomodulator. DARU 2009;17:148-56.
39. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008;65:1631-52.
40. Roghani Dehkordi F, Roghani M, Baluchnejadmojarad T. The effect of curcumin on serum level of aspartate and alanine amoinotransferase and cardiac level of oxidative stress markers in diabetic rats. Pajoohandeh 2012;17:18-25.
41. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
42. Huang S, Beevers C. Pharmacological and clinical properties of curcumin. Botanics: Targets Ther 2011;1:5-18.
43. Abdel Aziz MT, El-Asmar MF, El-Ibrashy IN, Rezq AM, Al-Malki AL, Wassef MA, et al.. Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short-term study). Diabetol Metab Syndr 2012;4:30.
44. Yang CS, Sang S, Lambert JD, Lee MJ. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 2008;52(Suppl. 1):S139-51.
45. Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs & monkeys. Indian J Exp Biol 1980;18:73-5.
46. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al.. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;6:10.
47. Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D 2008;9:243-50.
48. Sajithlal GB, Chithra P, Gowri C. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 1998;56:1607e14.
49. Shetty AK, Rashmi R, Rajan MGR, Sambaiah K, Salimath PV. Antidiabetic influence of quercetin in streptozotocin induced diabetic rats. Nutr Res 2004;24:373e81.
50. Abdelmoaty MA, Ibrahim MA, Ahmed NS, Abdelaziz MA. Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J Clin Biochem 2010;25:188-92.
51. Kim JH, Kang MJ, Choi HN, Jeong SM, Lee YM, Kim JI. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr Res Pract 2011;5:107-11.
52. Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol 2010;48:3246-61.
53. Chuang CC, Martinez K, Xie G, Kennedy A, Bumrungpert A, Overman A, et al.. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr 2010;92:1511-21.
54. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. Review of 97 bioavailability studies. Am J Clin Nutr 2005;81(Suppl. 1):230-42.